search
Back to results

Management of Patients With Keratoconus With Intacs

Primary Purpose

Keratoconus

Status
Terminated
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Intacs
Sponsored by
University Hospital of Crete
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Keratoconus focused on measuring keratoconus, Intacs

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • All patients had clear central corneas and contact lens intolerance (rigid gas permeable contact lenses intolerance, frequent contact lens displacement, unsatisfactory visual acuity),

Exclusion Criteria:

  • history of herpes keratitis; diagnosed autoimmune disease; and systemic connective tissue disease.

Sites / Locations

    Outcomes

    Primary Outcome Measures

    refractive stability, UCVA, BSCVA, complications

    Secondary Outcome Measures

    Full Information

    First Posted
    October 5, 2006
    Last Updated
    October 5, 2006
    Sponsor
    University Hospital of Crete
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00384501
    Brief Title
    Management of Patients With Keratoconus With Intacs
    Official Title
    Intacs for the Treatment of Keratoconus
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2006
    Overall Recruitment Status
    Terminated
    Study Start Date
    January 2000 (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    July 2006 (undefined)

    3. Sponsor/Collaborators

    Name of the Sponsor
    University Hospital of Crete

    4. Oversight

    5. Study Description

    Brief Summary
    Purpose To evaluate long-term follow up of Intacs microthin prescription inserts (Addition Technology Inc, Fremont, Calif) for the management of keratoconus. Design A long-term (five years) retrospective, follow-up study
    Detailed Description
    Subjects and Methods Ethical committee approval was obtained for the original trial, and patients were asked to sign an informed consent form (in accordance with Institutional guidelines and to the Declaration of Helsinki) before treatment and for further follow-up examinations. The registration information for this clinical trial is available to the public through the National Institute of Health database. The surgical procedure was done under topical anesthesia. Two Intacs segments of 0.45-mm thickness were inserted so as to embrace the steepest keratoconus meridian, according to the topographic image, aiming at maximal flattening. The corneal thickness was measured intraoperatively at the incision site and peripherally in the cornea along the ring placement markings with ultrasonic pachymetry (Sonogage, Cleveland, Ohio, USA). Using a diamond knife, set at 70% of the thinnest corneal measurement, a 0.9-mm radial incision was formed, and corneal pockets were created using two Sinskey hooks and a Suarez spreader. Two corneal tunnels were then formed using clockwise and counterclockwise dissectors under suction created by a vacuum-centering guide. The two polymethyl methacrylate (PMMA) segments (0.45-mm thickness) were implanted in the respective corneal tunnels, maintaining a space of approximately 2.0-mm between their ends and 1.5 mm between the opposite edge of each segment and the edge of the incision. The incision site was sutured using a single 10/0 nylon stitch. Postoperative evaluation Postoperatively, all eyes received antibiotic/steroid combination eye drops 4 times per day for 2 weeks. In addition, all patients were instructed to use preservative-free artificial tears frequently. The sutures were removed 2 weeks after surgery. Group differences for continuous variables were tested using the paired Student t tests. The change in manifest refraction (spherical equivalent) (MRSE) and topographic k values and topographic astigmatism were plotted over time to determine long-term stability, and the difference as a function of time was analyzed using paired 2-tailed t tests (at time intervals of preoperative to 1 month, 1 to 3 months, 3 to 6 months, 6 to 12 months, and every year of follow up period). Results are presented as means + standard deviation [SD]. A P value less than .05 was regarded as statistically significant.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Keratoconus
    Keywords
    keratoconus, Intacs

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    25 (false)

    8. Arms, Groups, and Interventions

    Intervention Type
    Device
    Intervention Name(s)
    Intacs
    Primary Outcome Measure Information:
    Title
    refractive stability, UCVA, BSCVA, complications

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: All patients had clear central corneas and contact lens intolerance (rigid gas permeable contact lenses intolerance, frequent contact lens displacement, unsatisfactory visual acuity), Exclusion Criteria: history of herpes keratitis; diagnosed autoimmune disease; and systemic connective tissue disease.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    George D Kymionis, M.D., Ph.D
    Organizational Affiliation
    University of Crete
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    16814056
    Citation
    Alio JL, Shabayek MH, Artola A. Intracorneal ring segments for keratoconus correction: long-term follow-up. J Cataract Refract Surg. 2006 Jun;32(6):978-85. doi: 10.1016/j.jcrs.2006.02.044.
    Results Reference
    result

    Learn more about this trial

    Management of Patients With Keratoconus With Intacs

    We'll reach out to this number within 24 hrs